Conference abstract · 17 Feb 2022
Mini reviewPublished 31 Jul 2023
Debunking Myths and Misconceptions about Double-blind Studies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Double-blind studies are a cornerstone of scientific research, particularly in the fields of medicine and psychology. However, there are several myths and misconceptions surrounding these studies that can lead to confusion and skepticism. This article aims to debunk these myths and provide a clear understanding of the importance, principles and limitations of double-blind studies. By addressing common misconceptions, readers can gain a deeper appreciation of the rigor and reliability of double-blind research, which ultimately contributes to advancing our understanding of the world.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2022
Efficacy of UC-II ® Undenatured Type II Collagen on Knee Joint Function in Healthy Subjects: An Exploratory Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
Research article · 27 Jul 2021
A Double-Blind Randomized, Placebo-Controlled Phase 2 Clinical Trial to Evaluate Safety and Efficacy of US APR 2020 in Subjects with Chronic Kidney Disease Stage IV
Commentary · 24 Mar 2020
Commentary on Treating Impulsivity with Probiotics in Adults (PROBIA): Study Protocol of a Multicenter, Double-blind, Randomized, Placebo-Controlled Trial
Other · 2018
The Efficacy of the Kampo Formula Keishikashakuyakuto for Irritable Bowel Syndrome: A Phase 3, Multicenter, Double-Blind, Placebo- Controlled, Randomized Controlled Trial
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Muratsubaki Butawan”

